ENDEFR
Home › Ireland › REGENERON IRELAND DESIGNATED ACTIVITY COMPANY

REGENERON IRELAND DESIGNATED ACTIVITY COMPANY

Designated Activity Company (DAC – (limited by shares)) · DUBLIN, Ireland · LEI 635400NABUOXXFAMHX81
LEI active

Summary

REGENERON IRELAND DESIGNATED ACTIVITY COMPANY is registered in Ireland and entered in the “Companies Register (CRO)” under number 519550. Its legal form is Designated Activity Company (DAC – (limited by shares)). According to GLEIF, its ultimate parent is REGENERON PHARMACEUTICALS, INC. (United States), which is also its direct parent. That group has 2 subsidiaries with LEIs in 3 countries, 1 of them in Ireland. The LEI was first issued on 28 Mar 2019 and the record was last updated on 9 Dec 2025; the next renewal is due by 1 Feb 2027. GLEIF's ISIN mapping lists 6 ISINs for this LEI.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formDesignated Activity Company (DAC – (limited by shares))
RegisterCompanies Register (CRO) · Register website
Registration number519550
Registration authorityCompanies Registration Office
JurisdictionIreland
Registered addressONE WARRINGTON PLACE, D02 HH27 DUBLIN, Ireland
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)1 Nov 2012
LEI635400NABUOXXFAMHX81
LEI statusactive
LEI first issued28 Mar 2019
LEI record last updated9 Dec 2025
Next LEI renewal1 Feb 2027
Corroboration of the LEI recordfully corroborated

Group membership

REGENERON PHARMACEUTICALS, INC. United States ultimate parent
REGENERON IRELAND DESIGNATED ACTIVITY COMPANY this entity
View the whole group: 2 subsidiaries in 3 countries

Relationship to the parent

Direct parentUltimate parent
ParentREGENERON PHARMACEUTICALS, INC.REGENERON PHARMACEUTICALS, INC.
Accounting period1 Jan 2024 to 31 Dec 20241 Jan 2024 to 31 Dec 2024
Evidenceconsolidated accountsconsolidated accounts
Corroborationfully corroboratedfully corroborated
Accounting standardUS GAAPUS GAAP
Relationship start20 Oct 202116 Feb 2021
Recorded at GLEIF since28 Mar 201928 Mar 2019
Last updated9 Dec 20259 Dec 2025
Record statuscurrentcurrent

ISINs mapped to this LEI (6)

IE00BJ5JSH78 · IE00BJ5JSJ92 · IE00BJ5JSK08 · IE00BJ5JSL15 · IE00BNKF0722 · IE00BNKF0839

6 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.